Novavax Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones03-26

DJ Novavax Inc. Stock Underperforms Wednesday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Novavax Inc. $(NVAX)$ shed 2.25% to $7.39 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 2.04% to 17,899.01 and Dow Jones Industrial Average falling 0.31% to 42,454.79.

This was the stock's second consecutive day of losses.

Novavax Inc. closed 69.03% short of its 52-week high of $23.86, which the company achieved on June 6th.

The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ rose 0.43% to $161.72, Pfizer Inc. $(PFE)$ fell 1.33% to $25.21, and Merck & Co. Inc. $(MRK)$ rose 0.27% to $88.11.

Trading volume (2.9 M) remained 1.1 million below its 50-day average volume of 4.0 M.

Data source: Dow Jones Market Data, FactSet. Data compiled March 26, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

March 26, 2025 17:29 ET (21:29 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2522359893?lang=en_US&edition=full_marsco","thumbnail":"","is_english":true,"pubTime":"2025-03-27 05:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2522359893","market":"fut","top_or_hot":-1,"title":"Novavax Inc. Stock Underperforms Wednesday When Compared To Competitors","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Novavax Inc. Stock Underperforms Wednesday When Compared To Competitors\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Novavax Inc. <a href=\"https://laohu8.com/S/NVAX\">$(NVAX)$</a> shed 2.25% to $7.39 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index  falling 2.04% to 17,899.01 and Dow Jones Industrial Average  falling 0.31% to 42,454.79. \n</p>\n<p>\n     This was the stock's second consecutive day of losses. \n</p>\n<p>\n     Novavax Inc. closed 69.03% short of its 52-week high of $23.86, which the company achieved on June 6th. \n</p>\n<p>\n     The stock underperformed when compared to some of its competitors Wednesday, as Johnson &amp; Johnson <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a> rose 0.43% to $161.72, Pfizer Inc. <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> fell 1.33% to $25.21, and Merck &amp; Co. Inc. <a href=\"https://laohu8.com/S/MRK\">$(MRK)$</a> rose 0.27% to $88.11. \n</p>\n<p>\n     Trading volume (2.9 M) remained 1.1 million below its 50-day average volume of 4.0 M. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled March 26, 2025. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 26, 2025 17:29 ET (21:29 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax Inc. Stock Underperforms Wednesday When Compared To Competitors</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax Inc. Stock Underperforms Wednesday When Compared To Competitors\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-03-27 05:29</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Novavax Inc. Stock Underperforms Wednesday When Compared To Competitors\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Novavax Inc. <a href=\"https://laohu8.com/S/NVAX\">$(NVAX)$</a> shed 2.25% to $7.39 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index  falling 2.04% to 17,899.01 and Dow Jones Industrial Average  falling 0.31% to 42,454.79. \n</p>\n<p>\n     This was the stock's second consecutive day of losses. \n</p>\n<p>\n     Novavax Inc. closed 69.03% short of its 52-week high of $23.86, which the company achieved on June 6th. \n</p>\n<p>\n     The stock underperformed when compared to some of its competitors Wednesday, as Johnson &amp; Johnson <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a> rose 0.43% to $161.72, Pfizer Inc. <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> fell 1.33% to $25.21, and Merck &amp; Co. Inc. <a href=\"https://laohu8.com/S/MRK\">$(MRK)$</a> rose 0.27% to $88.11. \n</p>\n<p>\n     Trading volume (2.9 M) remained 1.1 million below its 50-day average volume of 4.0 M. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled March 26, 2025. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 26, 2025 17:29 ET (21:29 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NVAX","symbol_name":"诺瓦瓦克斯医药","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2522359893","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2522359893","pubTimestamp":1743024540,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Novavax Inc.  shed 2.25% to $7.39 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index  falling 2.04% to 17,899.01 and Dow Jones Industrial Average  falling 0.31% to 42,454.79.This was the stock's second consecutive day of losses.Novavax Inc. closed 69.03% short of its 52-week high of $23.86, which the company achieved on June 6th.The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson  rose 0.43% to $161.72, Pfizer Inc.  fell 1.33% to $25.21, and Merck & Co. Inc.  rose 0.27% to $88.11.Trading volume  remained 1.1 million below its 50-day average volume of 4.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled March 26, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswir","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"translate_title":"与竞争对手相比，Novavax Inc.股票周三表现不佳","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NVAX":1},"content_text":"DJ Novavax Inc. Stock Underperforms Wednesday When Compared To Competitors\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     Shares of Novavax Inc. $(NVAX)$ shed 2.25% to $7.39 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index  falling 2.04% to 17,899.01 and Dow Jones Industrial Average  falling 0.31% to 42,454.79. \n\n\n     This was the stock's second consecutive day of losses. \n\n\n     Novavax Inc. closed 69.03% short of its 52-week high of $23.86, which the company achieved on June 6th. \n\n\n     The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ rose 0.43% to $161.72, Pfizer Inc. $(PFE)$ fell 1.33% to $25.21, and Merck & Co. Inc. $(MRK)$ rose 0.27% to $88.11. \n\n\n     Trading volume (2.9 M) remained 1.1 million below its 50-day average volume of 4.0 M. \n\n\n     Data source: Dow Jones Market Data, FactSet. Data compiled March 26, 2025. \n\n\n     This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 26, 2025 17:29 ET (21:29 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.33.1","shortVersion":"4.33.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2522359893"}